| Pre- injection (T0) | 2- months FU (T1) | 1-year FU (T2) | 2-year FU (T3) | p-value |
---|---|---|---|---|---|
Mean months after IACs (SD) | 0 n = 15 | 2.4 ± 1.6 n = 14 | 12.3 ± 1.5 n = 15 | 21.5 ± 2.6 n = 11 |  |
Additive Inflammatory domain: (Bone marrow edema, bone marrow enhancement, Joint effusion, Synovial thickening, Joint enhancement) | 4.4 ± 1.8 | 3.4 ± 2.0 n = 13 | 3.6 ± 1.7 n = 14 | 2.3 ± 1.7 n = 10 | 0.040* a |
Bone marrow edema | 0.3 ± 0.5 | 0.1 ± 0.3 | 0.1 ± 0.4 n = 14 | 0.0 ± 0.0 n = 10 | 0.500* b |
Bone marrow enhancement | 0.4 ± 0.5 | 0.2 ± 0.4 n = 13 | 0.1 ± 0.4 n = 14 | 0.0 ± 0.0 n = 11 | 0.250* b |
Joint effusion | 0.8 ± 0.9 | 0.7 ± 0.8 n = 14 | 0.6 ± 0.9 n = 14 | 0.3 ± 0.7 n = 10 | 0.705* a |
Synovial thickening | 1.0 ± 0.8 | 1.0 ± 0.8 n = 14 | 1.0 ± 0.8 n = 14 | 0.7 ± 0.8 n = 10 | 1.000* a |
Joint enhancement | 1.9 ± 0.3 | 1.5 ± 0.7 n = 13 | 1.8 ± 0.4 n = 14 | 1.3 ± 0.6 n = 11 | 0.059* a |
Additive Damage domain: (Condylar flattening, erosions, disc abnormalities) | 2.6 ± 1.5 | 2.8 ± 1.5 n = 14 | 2.7 ± 1.6 | 2.5 ± 1.7 n = 10 | 1.000** a |
Condylar flattening | 1.3 ± 0.9 | 1.6 ± 0.8 n = 14 | 1.5 ± 0.9 | 1.5 ± 0.9 n = 11 | 0.157** a |
Erosions | 0.6 ± 0.7 | 0.6 ± 0.8 n = 14 | 0.5 ± 0.8 | 0.4 ± 0.7 n = 10 | 0.655** a |
Disc abnormalities | 0.7 ± 0.5 | 0.6 ± 0.5 n = 14 | 0.7 ± 0.5 | 0.7 ± 0.5 n = 11 | 1.000** b |
Progressive inflammation | 2.6 ± 0.8 | 2.0 ± 1.1 n = 13 | 2.5 ± 1.0 n = 14 | 1.5 ± 0.9 n = 11 | 0.066* a |
Progressive osseous deformity | 2.0 ± 1.3 | 2.1 ± 1.1 n = 14 | 2.0 ± 1.4 | 2.0 ± 1.3 n = 11 | 1.000** a |